These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 16391862)
1. mHFE7A, a newly identified monoclonal antibody to Fas, induces apoptosis in human melanoma cells in vitro and delays the growth of melanoma xenotransplants. Hiramoto K; Inui M; Kamei T; Okumura K; Nakase M; Tagawa T Oncol Rep; 2006 Feb; 15(2):409-15. PubMed ID: 16391862 [TBL] [Abstract][Full Text] [Related]
2. A novel dietary triterpene Lupeol induces fas-mediated apoptotic death of androgen-sensitive prostate cancer cells and inhibits tumor growth in a xenograft model. Saleem M; Kweon MH; Yun JM; Adhami VM; Khan N; Syed DN; Mukhtar H Cancer Res; 2005 Dec; 65(23):11203-13. PubMed ID: 16322271 [TBL] [Abstract][Full Text] [Related]
3. FR901228 induces tumor regression associated with induction of Fas ligand and activation of Fas signaling in human osteosarcoma cells. Imai T; Adachi S; Nishijo K; Ohgushi M; Okada M; Yasumi T; Watanabe K; Nishikomori R; Nakayama T; Yonehara S; Toguchida J; Nakahata T Oncogene; 2003 Dec; 22(58):9231-42. PubMed ID: 14647441 [TBL] [Abstract][Full Text] [Related]
4. Growth-inhibitory effects of human anti-insulin-like growth factor-I receptor antibody (A12) in an orthotopic nude mouse model of anaplastic thyroid carcinoma. Wang Z; Chakravarty G; Kim S; Yazici YD; Younes MN; Jasser SA; Santillan AA; Bucana CD; El-Naggar AK; Myers JN Clin Cancer Res; 2006 Aug; 12(15):4755-65. PubMed ID: 16899627 [TBL] [Abstract][Full Text] [Related]
5. FTY720 induced Bcl-associated and Fas-independent apoptosis in human renal cancer cells in vitro and significantly reduced in vivo tumor growth in mouse xenograft. Ubai T; Azuma H; Kotake Y; Inamoto T; Takahara K; Ito Y; Kiyama S; Sakamoto T; Horie S; Muto S; Takahara S; Otsuki Y; Katsuoka Y Anticancer Res; 2007; 27(1A):75-88. PubMed ID: 17352219 [TBL] [Abstract][Full Text] [Related]
6. Acquisition of Fas resistance by Fas receptor mutation in a childhood B-precursor acute lymphoblastic leukemia cell line, MML-1. Inaba H; Shimada K; Zhou YW; Ido M; Buck S; Yonehara S; Kaplan J; Komada Y Int J Oncol; 2005 Aug; 27(2):573-9. PubMed ID: 16010441 [TBL] [Abstract][Full Text] [Related]
7. Aspirin sensitizes cancer cells to TRAIL-induced apoptosis by reducing survivin levels. Lu M; Strohecker A; Chen F; Kwan T; Bosman J; Jordan VC; Cryns VL Clin Cancer Res; 2008 May; 14(10):3168-76. PubMed ID: 18483385 [TBL] [Abstract][Full Text] [Related]
8. Crosstalk between extrinsic and intrinsic cell death pathways in pancreatic cancer: synergistic action of estrogen metabolite and ligands of death receptor family. Basu A; Castle VP; Bouziane M; Bhalla K; Haldar S Cancer Res; 2006 Apr; 66(8):4309-18. PubMed ID: 16618756 [TBL] [Abstract][Full Text] [Related]
9. Systemic anti-hepatocyte growth factor monoclonal antibody therapy induces the regression of intracranial glioma xenografts. Kim KJ; Wang L; Su YC; Gillespie GY; Salhotra A; Lal B; Laterra J Clin Cancer Res; 2006 Feb; 12(4):1292-8. PubMed ID: 16489086 [TBL] [Abstract][Full Text] [Related]
10. A chimeric SM5-1 antibody inhibits hepatocellular carcinoma cell growth and induces caspase-dependent apoptosis. Dai J; Jin J; Li B; Wang H; Hou S; Qian W; Kou G; Zhang D; Li J; Tan M; Ma J; Guo Y Cancer Lett; 2007 Dec; 258(2):208-14. PubMed ID: 17959303 [TBL] [Abstract][Full Text] [Related]
11. Antirheumatic effects of humanized anti-Fas monoclonal antibody in human rheumatoid arthritis/SCID mouse chimera. Matsuno H; Yudoh K; Nakazawa F; Sawai T; Uzuki M; Nishioka K; Yonehara S; Nakayama J; Ohtsuki M; Kimura T J Rheumatol; 2002 Aug; 29(8):1609-14. PubMed ID: 12180717 [TBL] [Abstract][Full Text] [Related]
12. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin. Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094 [TBL] [Abstract][Full Text] [Related]
13. FasL gene therapy: a new therapeutic modality for head and neck cancer. ElOjeimy S; McKillop JC; El-Zawahry AM; Holman DH; Liu X; Schwartz DA; Day TA; Dong JY; Norris JS Cancer Gene Ther; 2006 Aug; 13(8):739-45. PubMed ID: 16543918 [TBL] [Abstract][Full Text] [Related]
14. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models. Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998 [TBL] [Abstract][Full Text] [Related]
15. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo. Katiyar SK; Meeran SM; Katiyar N; Akhtar S Mol Carcinog; 2009 Jan; 48(1):24-37. PubMed ID: 18459128 [TBL] [Abstract][Full Text] [Related]
16. Lupeol inhibits growth of highly aggressive human metastatic melanoma cells in vitro and in vivo by inducing apoptosis. Saleem M; Maddodi N; Abu Zaid M; Khan N; bin Hafeez B; Asim M; Suh Y; Yun JM; Setaluri V; Mukhtar H Clin Cancer Res; 2008 Apr; 14(7):2119-27. PubMed ID: 18381953 [TBL] [Abstract][Full Text] [Related]